Inherited Disorders of Sodium and Water Handling

Comprehensive Clinical Nephrology: Fourth Edition

Volumn , Issue , 2010, Pages 573-583

  Gross, Peter ^a   Heduschka, Peter ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882930447     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-05876-6.00047-2     Document Type: Chapter

References (33)

1. Bartter FC, Pronove P, Gill J, MacCardle R Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med 1962, 33:811-828.
2. Gitelman HJ, Graham JB, Welt LG A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966, 79:221-235.
3. Shaer AJ Inherited primary renal tubular hypokalemic alkalosis: A review of Gitelman and Bartter syndromes. Am J Med Sci 2001, 322:316-332.
4. - co-transporter NKCC2. Nat Genet 1996, 13:183-188.
5. International Collaborative Study Group for Bartter-like Syndromes Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: Evidence for genetic heterogeneity. Hum Mol Genet 1997, 6:17-26.
6. Birkenhager R, Otto E, Schurmann MJ, et al. Mutations of BSND cause Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 2001, 29:310-314.
7. Zelikovic I, Szargel R, Hawash A, et al. A novel mutation in the chloride channel gene, ClCKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 2003, 63:24-32.
8. Vargas-Poussou R, Huang C, Hulin P, et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter like syndrome. J Am Soc Nephrol 2002, 13:2259-2266.
9. Dillon MJ, Shah V, Mitchell MD Bartter syndrome: 10 cases in childhood. Results of long term indomethacin therapy. Q J Med 1979, 48:429-446.
10. - co-transporter. Nat Genet 1996, 12:24-30.
11. Liddle GW, Bledsoe T, Coppage WS A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians 1963, 76:199-213.
12. Palmer BF, Alpern RJ Liddle's syndrome. Am J Med 1998, 104:310-319.
13. Rossier BC, Pradervand S, Schild L, Hummler E Epithelial sodium channel and the control of sodium balance: Interaction between genetic and environmental factors. Annu Rev Physiol 2002, 64:877-897.
14. Botero-Velez M, Curtis JJ, Warnock DG Liddle's syndrome revisited: A disorder of sodium reabsorption in the distal tubule. N Engl J Med 1994, 330:178-181.
15. Geller DS, Farhi A, Pinkerton N, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000, 289:119-123.
16. White PC Abnormalities of aldosterone synthesis and action in children. Curr Opin Pediatr 1997, 9:424-430.
17. Stewart PM, Krozowski Z, Gupta A, et al. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutations of the 11β-hydroxysteroid dehydrogenase type 2 gene. Lancet 1996, 347:88-91.
18. White PC 11β-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. Am J Med Sci 2001, 322:308-315.
19. Palermo M, Delitala G, Mantero F, et al. Congenital deficiency of 11β-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): Diagnostic value of urinary free cortisol and cortisone. J Endocrinol Invest 2001, 24:17-23.
20. Li A, Tedde R, Krozowski ZS, et al. Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess. Am J Hum Genet 1998, 63:370-379.
21. Palermo M, Delitala G, Sorba G, et al. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?. J Endocrinol Invest 2000, 23:457-462.
22. McMahon GT, Dluhy RG Glucocorticoid-remediable aldosteronism. Cardiol Rev 2004, 12:44-48.
23. Dillon MJ, Leonard JV, Buckler JM, et al. Pseudohypoaldosteronism. Arch Dis Child 1980, 55:427-434.
24. Geller DS, Rodriguez-Soriano J, Vallo Boado A, et al. Mutations in the mineralocorticoid receptor gene causes autosomal dominant pseudohypoaldosteronism type 1. Nat Genet 1998, 19:279-281.
25. Chang SS, Grunder S, Hanukoglu A, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996, 12:248-253.
26. White PC Aldosterone synthase deficiency and related disorders. Mol Cell Endocrinol 2004, 217:81-87.
27. Speiser PW Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Endocrinol Metab Clin North Am 2001, 30:31-59.
28. Mein CA, Caulfield MJ, Dobson RJ, et al. Genetics of essential hypertension. Hum Mol Genet 2004, 13:169-175.
29. Bichet DG Vasopressin receptor mutations in nephrogenic diabetes insipidus. Semin Nephrol 2008, 28:245.
30. Sasaki S Nephrogenic diabetes insipidus: Update of genetic and clinical aspects. Nephrol Dial Transplant 2004, 19:1351-1353.
31. Bichet DG, Oksche A, Rosenthal W Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1997, 8:1951-1958.
32. Heppner C, Kotzka J, Bullmann C, et al. Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus. J Clin Endocrinol Metab 1998, 83:693-696.
33. Nguyen MK, Nielsen S, Kurtz I Molecular pathogenesis of nephrogenic diabetes insipidus. Clin Exp Nephrol 2003, 7:9-17.